Results 251 to 260 of about 59,535 (272)
Some of the next articles are maybe not open access.
[Change of ESBLs-KPN and ESBLs-ECO after antimicrobial intervention].
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2010To evaluate the change of extended spectrum beta-lactamase (ESBLs) Producing Klebsiella Pneumoniae (ESBLs-KPN) and Escherichia coli (ESBLs-ECO) causing nosocomial infection after antimicrobial intervention.We regularly monitored the data on the yearly consumption [defined as daily dose (DDD) per 1 000 patient-days] of frequently used antibiotics from ...
Yu Yang +4 more
openaire +3 more sources
Characterization of ESBL disseminating plasmids
Infectious Diseases, 2015Bacteria producing extended-spectrum β-lactamases (ESBLs) constitute a globally increasing problem that contributes to treatment complications and elevated death rates. The extremely successful dissemination by ESBL-producing Enterobacteriaceae during the latest decades is a result of the combination of mobilization, evolution and horizontal spread of ...
Linus Sandegren, Alma Brolund
openaire +2 more sources
DMW - Deutsche Medizinische Wochenschrift, 2012
Extended-spectrum beta-lactamases (ESBLs), which confer resistance to third generation cephalosporins, demonstrate how rapidly resistance mechanisms can evolve. These enzymes were discovered in few isolates in the late 1980s. They have now reached significant levels in hospitals and the community worldwide. Different ESBL enzyme variants (TEM, SHV, CTX-
openaire +3 more sources
Extended-spectrum beta-lactamases (ESBLs), which confer resistance to third generation cephalosporins, demonstrate how rapidly resistance mechanisms can evolve. These enzymes were discovered in few isolates in the late 1980s. They have now reached significant levels in hospitals and the community worldwide. Different ESBL enzyme variants (TEM, SHV, CTX-
openaire +3 more sources
Infection control and hospital epidemiology, 2019
Objective: To determine whether colonization with extended-spectrum β-lactamase–producing Enterobacteriaceae (ESBL-PE) predicts the risk for subsequent infection and impacts carbapenem-consumption and outcome in intensive care unit (ICU) patients. Design:
A. Martinez +7 more
semanticscholar +1 more source
Objective: To determine whether colonization with extended-spectrum β-lactamase–producing Enterobacteriaceae (ESBL-PE) predicts the risk for subsequent infection and impacts carbapenem-consumption and outcome in intensive care unit (ICU) patients. Design:
A. Martinez +7 more
semanticscholar +1 more source
Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen
Journal of Clinical Microbiology, 1996Resistance to contemporary broad-spectrum beta-lactams, mediated by extended-spectrum beta-lactamase (ESBL) enzymes, is an increasing problem worldwide. The Etest (AB Biodisk, Solna, Sweden) ESBL screen uses stable gradient technology to evaluate the MIC of ceftazidime alone compared with the MIC of ceftazidime with clavulanic acid (2 micrograms/ml) to
Martin Cormican +2 more
openaire +2 more sources
Infection Control & Hospital Epidemiology, 2017
BACKGROUND Despite a reported worldwide increase, the incidence of extended-spectrum β-lactamase (ESBL) Escherichia coli and Klebsiella infections in the United States is unknown.
Jennifer S. McDanel +10 more
semanticscholar +1 more source
BACKGROUND Despite a reported worldwide increase, the incidence of extended-spectrum β-lactamase (ESBL) Escherichia coli and Klebsiella infections in the United States is unknown.
Jennifer S. McDanel +10 more
semanticscholar +1 more source